Glaxo hid the truth for 40 years.

The British manufacturer hid the risk of developing cancer when taking the popular drug Zantac for 40 years. For the first time, studies confirming that the medicine for stomach ulcers and heartburn "Zantac" can cause the development of cancer appeared in 1978, when its release began. The manufacturer, the British pharmaceutical company Glaxo, withheld this information. The drug was the world's best-selling prescription drug. The company received an award from Queen Elizabeth II for its success. In 2019, it became known that the active substance of the drug, ranitidine, contains a carcinogen. After that, it was banned from sale.